Skip to main content
Erschienen in: European Journal of Nutrition 3/2021

02.11.2020 | Review

CYP1A2 genotype and acute ergogenic effects of caffeine intake on exercise performance: a systematic review

verfasst von: Jozo Grgic, Craig Pickering, Juan Del Coso, Brad J. Schoenfeld, Pavle Mikulic

Erschienen in: European Journal of Nutrition | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To systematically review studies that examined the influence of the CYP1A2 −163C>A polymorphism on the ergogenic effects of caffeine and to discuss some of the reasons for the discrepancies in findings between the studies.

Methods

This review was performed in accordance with the PRISMA guidelines. The search for studies was performed through nine databases.

Results

Seventeen studies were included in the review. Based on the included studies, it seems that individuals with the AA or AC/CC genotype may experience an increase in performance following caffeine ingestion. Significant differences between genotypes were found in four studies, and all four reported a more favorable response in the AA vs. AC/CC genotype. These results suggest that if there is an actual genotype-related effect of acute caffeine supplementation, it might be in that direction. In the studies that reported such data for aerobic endurance, the findings are specific to male participants performing cycling time trials (distances of ≥ 10 km) and ingesting caffeine 60 min before exercise. For high-intensity exercise, two studies reported that genotype variations determined the response to caffeine ingestion, even though the differences were either small (~ 1 additional repetition in high-load resistance exercise set performed to muscular failure) or inconsistent (i.e., observed only in one out of eight performance tests).

Conclusions

CYP1A2 genotype variations may modulate caffeine’s ergogenic effects, but the differences between genotypes were small, inconsistent, or limited to specific exercise scenarios. Future studies with larger sample sizes are needed to fully elucidate this research area.
Literatur
1.
Zurück zum Zitat Mitchell DC, Knight CA, Hockenberry J et al (2014) Beverage caffeine intakes in the U.S. Food Chem Toxicol 63:136–142PubMed Mitchell DC, Knight CA, Hockenberry J et al (2014) Beverage caffeine intakes in the U.S. Food Chem Toxicol 63:136–142PubMed
2.
Zurück zum Zitat Del Coso J, Muñoz G, Muñoz-Guerra J (2011) Prevalence of caffeine use in elite athletes following its removal from the World Anti-Doping Agency list of banned substances. Appl Physiol Nutr Metab 36:555–561PubMed Del Coso J, Muñoz G, Muñoz-Guerra J (2011) Prevalence of caffeine use in elite athletes following its removal from the World Anti-Doping Agency list of banned substances. Appl Physiol Nutr Metab 36:555–561PubMed
3.
Zurück zum Zitat Grgic J, Grgic I, Pickering C et al (2020) Wake up and smell the coffee: caffeine supplementation and exercise performance—an umbrella review of 21 published meta-analyses. Br J Sports Med 54:681–688PubMed Grgic J, Grgic I, Pickering C et al (2020) Wake up and smell the coffee: caffeine supplementation and exercise performance—an umbrella review of 21 published meta-analyses. Br J Sports Med 54:681–688PubMed
4.
Zurück zum Zitat Sabol F, Grgic J, Mikulic P (2019) The effects of 3 different doses of caffeine on jumping and throwing performance: a randomized, double-blind, crossover study. Int J Sports Physiol Perform 14:1170–1177 Sabol F, Grgic J, Mikulic P (2019) The effects of 3 different doses of caffeine on jumping and throwing performance: a randomized, double-blind, crossover study. Int J Sports Physiol Perform 14:1170–1177
5.
Zurück zum Zitat Sachse C, Brockmöller J, Bauer S et al (1999) Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47:445–449PubMedPubMedCentral Sachse C, Brockmöller J, Bauer S et al (1999) Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47:445–449PubMedPubMedCentral
6.
Zurück zum Zitat Nehlig A (2018) Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev 70:384–411PubMed Nehlig A (2018) Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev 70:384–411PubMed
7.
Zurück zum Zitat Pickering C, Kiely J (2018) Are the current guidelines on caffeine use in sport optimal for everyone? Inter-individual variation in caffeine ergogenicity, and a move towards personalised sports nutrition. Sports Med 48:7–16PubMed Pickering C, Kiely J (2018) Are the current guidelines on caffeine use in sport optimal for everyone? Inter-individual variation in caffeine ergogenicity, and a move towards personalised sports nutrition. Sports Med 48:7–16PubMed
8.
Zurück zum Zitat Wang L, Hu Z, Deng X et al (2013) Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers. Basic Clin Pharmacol Toxicol 122:257–263 Wang L, Hu Z, Deng X et al (2013) Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers. Basic Clin Pharmacol Toxicol 122:257–263
9.
Zurück zum Zitat Algrain HA, Thomas RM, Carrillo AE et al (2016) The effects of a polymorphism in the cytochrome P450 CYP1A2 gene on performance enhancement with caffeine in recreational cyclists. J Caffeine Res 6:34–39 Algrain HA, Thomas RM, Carrillo AE et al (2016) The effects of a polymorphism in the cytochrome P450 CYP1A2 gene on performance enhancement with caffeine in recreational cyclists. J Caffeine Res 6:34–39
10.
Zurück zum Zitat Davenport AD, Jameson TSO, Kilroe SP et al (2020) A randomised, placebo-controlled, crossover study investigating the optimal timing of a caffeine-containing supplement for exercise performance. Sports Med Open 6:17PubMedPubMedCentral Davenport AD, Jameson TSO, Kilroe SP et al (2020) A randomised, placebo-controlled, crossover study investigating the optimal timing of a caffeine-containing supplement for exercise performance. Sports Med Open 6:17PubMedPubMedCentral
11.
Zurück zum Zitat Giersch GE, Boyett JC, Hargens TA et al (2018) The effect of the CYP1A2-163 C>A polymorphism on caffeine metabolism and subsequent cycling performance. J Caffeine Adenosine Res 8:65–70 Giersch GE, Boyett JC, Hargens TA et al (2018) The effect of the CYP1A2-163 C>A polymorphism on caffeine metabolism and subsequent cycling performance. J Caffeine Adenosine Res 8:65–70
12.
Zurück zum Zitat Guest N, Corey P, Vescovi J et al (2018) Caffeine, CYP1A2 genotype, and endurance performance in athletes. Med Sci Sports Exerc 50:1570–1578PubMed Guest N, Corey P, Vescovi J et al (2018) Caffeine, CYP1A2 genotype, and endurance performance in athletes. Med Sci Sports Exerc 50:1570–1578PubMed
13.
Zurück zum Zitat Pataky MW, Womack CJ, Saunders MJ et al (2016) Caffeine and 3-km cycling performance: effects of mouth rinsing, genotype, and time of day. Scand J Med Sci Sports 26:613–619PubMed Pataky MW, Womack CJ, Saunders MJ et al (2016) Caffeine and 3-km cycling performance: effects of mouth rinsing, genotype, and time of day. Scand J Med Sci Sports 26:613–619PubMed
14.
Zurück zum Zitat Pickering C, Kiely J, Grgic J et al (2019) Can genetic testing identify talent for sport? Genes 10:E972PubMed Pickering C, Kiely J, Grgic J et al (2019) Can genetic testing identify talent for sport? Genes 10:E972PubMed
15.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700PubMedPubMedCentral Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700PubMedPubMedCentral
16.
Zurück zum Zitat Maher CG, Sherrington C, Herbert RD et al (2003) Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 83:713–721PubMed Maher CG, Sherrington C, Herbert RD et al (2003) Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 83:713–721PubMed
17.
Zurück zum Zitat McCrary JM, Ackermann BJ, Halaki M (2015) A systematic review of the effects of upper body warm-up on performance and injury. Br J Sports Med 49:935–942PubMed McCrary JM, Ackermann BJ, Halaki M (2015) A systematic review of the effects of upper body warm-up on performance and injury. Br J Sports Med 49:935–942PubMed
18.
Zurück zum Zitat Grgic J, Pickering C, Bishop DJ et al (2020) CYP1A2 genotype and acute effects of caffeine on resistance exercise, jumping, and sprinting performance. J Int Soc Sports Nutr 17:21PubMedPubMedCentral Grgic J, Pickering C, Bishop DJ et al (2020) CYP1A2 genotype and acute effects of caffeine on resistance exercise, jumping, and sprinting performance. J Int Soc Sports Nutr 17:21PubMedPubMedCentral
19.
Zurück zum Zitat Klein CS, Clawson A, Martin M et al (2012) The effect of caffeine on performance in collegiate tennis players. J Caffeine Res 2:111–116 Klein CS, Clawson A, Martin M et al (2012) The effect of caffeine on performance in collegiate tennis players. J Caffeine Res 2:111–116
20.
Zurück zum Zitat McGrath MC (2015) The significance of CYP1A2 genotype on caffeine metabolism and exercise performance. Thesis. Massey University McGrath MC (2015) The significance of CYP1A2 genotype on caffeine metabolism and exercise performance. Thesis. Massey University
21.
Zurück zum Zitat Potgieter S (2013) The effect of caffeine supplementation on Olympic-distance triathletes and triathlon performance in the Western Cape, South Africa. Dissertation. Stellenbosch University Potgieter S (2013) The effect of caffeine supplementation on Olympic-distance triathletes and triathlon performance in the Western Cape, South Africa. Dissertation. Stellenbosch University
22.
Zurück zum Zitat Puente C, Abián-Vicén J, Del Coso J et al (2018) The CYP1A2-163C>A polymorphism does not alter the effects of caffeine on basketball performance. PLoS One 13:e0195943PubMedPubMedCentral Puente C, Abián-Vicén J, Del Coso J et al (2018) The CYP1A2-163C>A polymorphism does not alter the effects of caffeine on basketball performance. PLoS One 13:e0195943PubMedPubMedCentral
23.
Zurück zum Zitat Rahimi R (2019) The effect of CYP1A2 genotype on the ergogenic properties of caffeine during resistance exercise: a randomized, double-blind, placebo-controlled, crossover study. Ir J Med Sci 188:337–345PubMed Rahimi R (2019) The effect of CYP1A2 genotype on the ergogenic properties of caffeine during resistance exercise: a randomized, double-blind, placebo-controlled, crossover study. Ir J Med Sci 188:337–345PubMed
24.
Zurück zum Zitat Salinero JJ, Lara B, Ruiz-Vicente D et al (2017) CYP1A2 genotype variations do not modify the benefits and drawbacks of caffeine during exercise: a pilot study. Nutrients 9:269PubMedCentral Salinero JJ, Lara B, Ruiz-Vicente D et al (2017) CYP1A2 genotype variations do not modify the benefits and drawbacks of caffeine during exercise: a pilot study. Nutrients 9:269PubMedCentral
25.
Zurück zum Zitat Southward K (2016) Effect of caffeine ingestion on aspects of endurance performance and cognition in CYP1A2 hetrozygous A/C male recreational athletes. Thesis. Massey University Southward K (2016) Effect of caffeine ingestion on aspects of endurance performance and cognition in CYP1A2 hetrozygous A/C male recreational athletes. Thesis. Massey University
26.
Zurück zum Zitat Womack CJ, Saunders MJ, Bechtel MK et al (2012) The influence of a CYP1A2 polymorphism on the ergogenic effects of caffeine. J Int Soc Sports Nutr 9:7PubMedPubMedCentral Womack CJ, Saunders MJ, Bechtel MK et al (2012) The influence of a CYP1A2 polymorphism on the ergogenic effects of caffeine. J Int Soc Sports Nutr 9:7PubMedPubMedCentral
27.
Zurück zum Zitat Carswell AT, Howland K, Martinez-Gonzalez B et al (2020) The effect of caffeine on cognitive performance is influenced by CYP1A2 but not ADORA2A genotype, yet neither genotype affects exercise performance in healthy adults. Eur J Appl Physiol 120:1495–1508PubMedPubMedCentral Carswell AT, Howland K, Martinez-Gonzalez B et al (2020) The effect of caffeine on cognitive performance is influenced by CYP1A2 but not ADORA2A genotype, yet neither genotype affects exercise performance in healthy adults. Eur J Appl Physiol 120:1495–1508PubMedPubMedCentral
28.
Zurück zum Zitat Muñoz A, López-Samanes Á, Aguilar-Navarro M et al (2020) Effects of CYP1A2 and ADORA2A genotypes on the ergogenic response to caffeine in professional handball players. Genes 11:E933PubMed Muñoz A, López-Samanes Á, Aguilar-Navarro M et al (2020) Effects of CYP1A2 and ADORA2A genotypes on the ergogenic response to caffeine in professional handball players. Genes 11:E933PubMed
30.
Zurück zum Zitat Shen JG, Brooks MB, Cincotta J et al (2019) Establishing a relationship between the effect of caffeine and duration of endurance athletic time trial events: a systematic review and meta-analysis. J Sci Med Sport 22:232–238PubMed Shen JG, Brooks MB, Cincotta J et al (2019) Establishing a relationship between the effect of caffeine and duration of endurance athletic time trial events: a systematic review and meta-analysis. J Sci Med Sport 22:232–238PubMed
31.
Zurück zum Zitat Chen HY, Wang HS, Tung K et al (2015) Effects of gender difference and caffeine supplementation on anaerobic muscle performance. Int J Sports Med 36:974–978PubMed Chen HY, Wang HS, Tung K et al (2015) Effects of gender difference and caffeine supplementation on anaerobic muscle performance. Int J Sports Med 36:974–978PubMed
32.
Zurück zum Zitat Skinner TL, Desbrow B, Arapova J et al (2019) Women experience the same ergogenic response to caffeine as men. Med Sci Sports Exerc 51:1195–1202PubMed Skinner TL, Desbrow B, Arapova J et al (2019) Women experience the same ergogenic response to caffeine as men. Med Sci Sports Exerc 51:1195–1202PubMed
33.
Zurück zum Zitat Gunes A, Ozbey G, Vural EH et al (2009) Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population. Pharmacogenomics 10:769–778PubMed Gunes A, Ozbey G, Vural EH et al (2009) Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population. Pharmacogenomics 10:769–778PubMed
34.
Zurück zum Zitat Koonrungsesomboon N, Khatsri R, Wongchompoo P et al (2018) The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis. Pharmacogenom J 18:760–768 Koonrungsesomboon N, Khatsri R, Wongchompoo P et al (2018) The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis. Pharmacogenom J 18:760–768
35.
Zurück zum Zitat Djordjevic N, Ghotbi R, Jankovic S et al (2010) Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism. Eur J Clin Pharmacol 66:697–703PubMed Djordjevic N, Ghotbi R, Jankovic S et al (2010) Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism. Eur J Clin Pharmacol 66:697–703PubMed
36.
Zurück zum Zitat Lampe JW, King IB, Li S et al (2000) Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis 21:1157–1162PubMed Lampe JW, King IB, Li S et al (2000) Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis 21:1157–1162PubMed
37.
Zurück zum Zitat Lane JD, Steege JF, Rupp SL et al (1992) Menstrual cycle effects on caffeine elimination in the human female. Eur J Clin Pharmacol 43:543–546PubMed Lane JD, Steege JF, Rupp SL et al (1992) Menstrual cycle effects on caffeine elimination in the human female. Eur J Clin Pharmacol 43:543–546PubMed
38.
Zurück zum Zitat Abernethy DR, Todd EL (1985) Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. Eur J Clin Pharmacol 28:425–428PubMed Abernethy DR, Todd EL (1985) Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. Eur J Clin Pharmacol 28:425–428PubMed
39.
Zurück zum Zitat Lara B, Gutiérrez-Hellín J, García-Bataller A et al (2020) Ergogenic effects of caffeine on peak aerobic cycling power during the menstrual cycle. Eur J Nutr 59:2525–2534PubMed Lara B, Gutiérrez-Hellín J, García-Bataller A et al (2020) Ergogenic effects of caffeine on peak aerobic cycling power during the menstrual cycle. Eur J Nutr 59:2525–2534PubMed
40.
Zurück zum Zitat Lara B, Gutiérrez Hellín J, Ruíz-Moreno C et al (2020) Acute caffeine intake increases performance in the 15-s Wingate test during the menstrual cycle. Br J Clin Pharmacol 86:745–752PubMedPubMedCentral Lara B, Gutiérrez Hellín J, Ruíz-Moreno C et al (2020) Acute caffeine intake increases performance in the 15-s Wingate test during the menstrual cycle. Br J Clin Pharmacol 86:745–752PubMedPubMedCentral
41.
Zurück zum Zitat Pickering C (2019) Caffeine, CYP1A2 genotype, and sports performance: is timing important? Ir J Med Sci 188:349–350PubMed Pickering C (2019) Caffeine, CYP1A2 genotype, and sports performance: is timing important? Ir J Med Sci 188:349–350PubMed
42.
Zurück zum Zitat Vistisen K, Poulsen HE, Loft S (1992) Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis 13:1561–1568PubMed Vistisen K, Poulsen HE, Loft S (1992) Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis 13:1561–1568PubMed
44.
Zurück zum Zitat Pareja-Blanco F, Rodríguez-Rosell D, Sánchez-Medina L et al (2017) Effects of velocity loss during resistance training on athletic performance, strength gains and muscle adaptations. Scand J Med Sci Sports 27:724–735PubMed Pareja-Blanco F, Rodríguez-Rosell D, Sánchez-Medina L et al (2017) Effects of velocity loss during resistance training on athletic performance, strength gains and muscle adaptations. Scand J Med Sci Sports 27:724–735PubMed
45.
Zurück zum Zitat Grgic J, Pickering C (2019) The effects of caffeine ingestion on isokinetic muscular strength: a meta-analysis. J Sci Med Sport 22:353–360PubMed Grgic J, Pickering C (2019) The effects of caffeine ingestion on isokinetic muscular strength: a meta-analysis. J Sci Med Sport 22:353–360PubMed
46.
Zurück zum Zitat Grgic J, Trexler ET, Lazinica B et al (2018) Effects of caffeine intake on muscle strength and power: a systematic review and meta-analysis. J Int Soc Sports Nutr 15:11PubMedPubMedCentral Grgic J, Trexler ET, Lazinica B et al (2018) Effects of caffeine intake on muscle strength and power: a systematic review and meta-analysis. J Int Soc Sports Nutr 15:11PubMedPubMedCentral
48.
Zurück zum Zitat Goldstein ER, Ziegenfuss T, Kalman D et al (2010) International society of sports nutrition position stand: caffeine and performance. J Int Soc Sports Nutr 7:5PubMedPubMedCentral Goldstein ER, Ziegenfuss T, Kalman D et al (2010) International society of sports nutrition position stand: caffeine and performance. J Int Soc Sports Nutr 7:5PubMedPubMedCentral
49.
Zurück zum Zitat Collomp K, Ahmaidi S, Chatard JC et al (1992) Benefits of caffeine ingestion on sprint performance in trained and untrained swimmers. Eur J Appl Physiol Occup Physiol 64:377–380PubMed Collomp K, Ahmaidi S, Chatard JC et al (1992) Benefits of caffeine ingestion on sprint performance in trained and untrained swimmers. Eur J Appl Physiol Occup Physiol 64:377–380PubMed
50.
Zurück zum Zitat Bell DG, McLellan TM (2002) Exercise endurance 1, 3, and 6 h after caffeine ingestion in caffeine users and nonusers. J Appl Physiol 93:1227–1234PubMed Bell DG, McLellan TM (2002) Exercise endurance 1, 3, and 6 h after caffeine ingestion in caffeine users and nonusers. J Appl Physiol 93:1227–1234PubMed
51.
Zurück zum Zitat Lara B, Ruiz-Moreno C, Salinero JJ et al (2019) Time course of tolerance to the performance benefits of caffeine. PLoS One 14:e0210275PubMedPubMedCentral Lara B, Ruiz-Moreno C, Salinero JJ et al (2019) Time course of tolerance to the performance benefits of caffeine. PLoS One 14:e0210275PubMedPubMedCentral
52.
Zurück zum Zitat Borenstein M, Hedges LV, Higgins JPT et al (2009) Introduction to meta-analysis. Wiley, Chichester Borenstein M, Hedges LV, Higgins JPT et al (2009) Introduction to meta-analysis. Wiley, Chichester
53.
Zurück zum Zitat Loy BD, O’Connor PJ, Lindheimer JB et al (2015) Caffeine is ergogenic for adenosine A2A receptor gene (ADORA2A) T allele homozygotes: a pilot study. J Caffeine Res 5:73–81 Loy BD, O’Connor PJ, Lindheimer JB et al (2015) Caffeine is ergogenic for adenosine A2A receptor gene (ADORA2A) T allele homozygotes: a pilot study. J Caffeine Res 5:73–81
54.
Zurück zum Zitat Grgic J, Pickering C, Bishop DJ et al (2020) ADORA2A C allele carriers exhibit ergogenic responses to caffeine supplementation. Nutrients 12:741PubMedCentral Grgic J, Pickering C, Bishop DJ et al (2020) ADORA2A C allele carriers exhibit ergogenic responses to caffeine supplementation. Nutrients 12:741PubMedCentral
Metadaten
Titel
CYP1A2 genotype and acute ergogenic effects of caffeine intake on exercise performance: a systematic review
verfasst von
Jozo Grgic
Craig Pickering
Juan Del Coso
Brad J. Schoenfeld
Pavle Mikulic
Publikationsdatum
02.11.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 3/2021
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-020-02427-6

Weitere Artikel der Ausgabe 3/2021

European Journal of Nutrition 3/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.